Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic <i>Escherichia coli</i> among Children in Zambia Participating in a Phase I Clinical Trial

Diarrhoeagenic <i>E. coli</i> (DEC) significantly contributes to the burden of diarrhoea among children. Currently, there is no approved vaccine against DEC, but several vaccines against the enterotoxigenic <i>E. coli</i> (ETEC) pathotype are in advanced clinical trial stages, including the ETVAX<su...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Kapambwe Mwape, Cynthia Mubanga, Obvious Nchimunya Chilyabanyama, Kennedy Chibesa, Caroline Cleopatra Chisenga, Suwilanji Silwamba, Arlo Randall, Xiaowu Liang, Tobias George Barnard, Michelo Simuyandi, Roma Chilengi
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2024-02-01
Rangatū:	Microorganisms
Ngā marau:	microarray vaccines diarrhoeagenic <i>E. coli</i> diarrhoea cross-reactivity ETVAX vaccine
Urunga tuihono:	https://www.mdpi.com/2076-2607/12/3/420
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!